Canopus Biopharma, Inc. (CBIA)
OTC
Healthcare
Medical - Pharmaceuticals
$0.00
▲ +0.00%
Market Cap
$455,071
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
8.90
52-Wk Range
0.0001-0.0001
CEO
Patrick T. Prendergast
Country
US
Currency
USD
Canopus Biopharma, Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Las Vegas, NV, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $455,071. On trailing twelve-month figures it carries a trailing P/E of -0.01, a net margin of 0.0%. Its beta of 8.90 implies it has historically moved more than the broad market.
Valuation & profitability (TTM)
P/E
-0.01
Price / Sales
0.00
Price / Book
-0.83
EV / EBITDA
-0.60
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
-0.77
Current ratio
0.24
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
72
IPO date
1999-12-31
Headquarters
Las Vegas, NV, US
About Canopus Biopharma, Inc.
Canopus Biopharma, Inc. engages in the acquisition of businesses. The company was founded on April 8, 1986 and is headquartered in Las Vegas, NV.
Comparable companies
Canopus Biopharma, Inc. is most often compared with the following Healthcare names:
More research on CBIA
Open full interactive analysis & DCF →